| Prev Close: | 7.50 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 12.00 |
| Beta: | N/A |
| Next Earnings Date: | 4-Nov-13 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 3.05 - 8.24 |
| Volume: | 0 |
| Avg Vol (3m): | 324,328 |
| Market Cap: | 278.26M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: Ampio Pharma subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of co's third US patent for its oxidation-reduction potential diagnostic platformBriefing.com(Tue, Oct 1)
- Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platformPR Newswire(Tue, Oct 1)
- Ampio announces positive result for Ampiontheflyonthewall.com(Mon, Sep 30)
- Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical TrialPR Newswire(Mon, Sep 30)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other EventsEDGAR Online(Thu, Sep 26)
- Why Ampio Pharmaceuticals, Inc. Shares Jumpedat Motley Fool(Thu, Sep 26)
- Ampio Pharmaceuticals, Inc. Announces $25 Million FinancingPR Newswire(Thu, Sep 26)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other EventsEDGAR Online(Tue, Sep 10)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other EventsEDGAR Online(Thu, Sep 5)
- 5 Stocks Under $10 Making Big Movesat TheStreet(Wed, Aug 28)
- Ampio Momentum Continues After Positive Initial Phase III Dataat Seeking Alpha(Mon, Aug 26)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and ExhiEDGAR Online(Tue, Aug 20)
- AMPIO PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Thu, Aug 15)
- Strong Phase III Ampion Data Released Wednesday: Setting The Stage For Ampioat Seeking Alpha(Thu, Aug 15)
- Ampio climbs on study of Ampion for knee painAP(Wed, Aug 14)
Press Releases
- Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platformPR Newswire(Tue, Oct 1)
- Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical TrialPR Newswire(Mon, Sep 30)
- Ampio Pharmaceuticals, Inc. Announces $25 Million FinancingPR Newswire(Thu, Sep 26)
Reports
- Thomson Reuters Stock Report - AMPIO PHARMACEUTICALS, INCORPORATION (AMPE-A)Thomson Reuters Stock Report(Oct 1)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(Oct 1)
- Industry Value Graph: AMPE , CBRX , CYAN , FURX , HZNP , RGEN -- DRUGSFord Investor Services, Inc.(Sep 27)